Financials
- Market Capitalization 1.09 T
- Employee 50 K
- Founded N/A
- CEO Kenji Tanaka
- Website www.lilly.com
- Headquarter Indiana, United States
- FIGI BBG000BNBDC2
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
40.25
Relación precio/flujo de caja
13.5
Dividendos por acción
3.46
Rendimiento por dividendo, %
1.31
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 17 | JNJ Johnson & Johnson Common Stock | 278.47 USD | +1.14% | +4.58% | +9.43% | +56.45% | 671.08 B USD | ||
| 23 | ABBV AbbVie Inc. Common Stock | 260.21 USD | -0.57% | +0.61% | +5.83% | +22.46% | 459.82 B USD | ||
| 31 | MRK Merck & Company, Inc. Common Stock | 152.34 USD | +0.41% | +4.15% | +18.58% | +80.97% | 375.85 B USD | ||
| 43 | NVS Novartis AG | 163.07 USD | +0.39% | +5.53% | +5.40% | +26.35% | 311.16 B USD |